Quarterly report pursuant to Section 13 or 15(d)

Significant Transactions (Details Textual)

Significant Transactions (Details Textual) - USD ($)
3 Months Ended
Jul. 07, 2020
Mar. 31, 2021
Dec. 31, 2020
Business Acquisition [Line Items]      
Common stock, shares issued   23,067,517 19,901,248
Voting preferred stock, par value   $ 0.0001  
Preferred stock liquidation, description   special voting preferred stock has a par value of $0.0001 per share and a preference in liquidation of $1.00.  
Ample Organics [Member]      
Business Acquisition [Line Items]      
Acquisition of description acquired 100% of the stock of Ample Organics for 3.3 million exchangeable shares of one of our wholly-owned subsidiaries. The exchangeable shares may be exchanged, at the option of the holder, for shares of Akerna common stock on a one-for-one basis, therefore the exchangeable shares issued were valued at $7.65 per share, the closing price of an equivalent share of Akerna common stock, $30.7 million was the aggregate value of the exchangeable shares. In addition to the stock consideration, we paid $5.5 million in cash, which was used to settle all of Ample's then outstanding debt. In addition to the stock and cash consideration, the agreement provides for contingent consideration of up to CAD$10,000,000, payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the 12 months after the acquisition date is CAD$9,000,000 or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000 and the amount of Recurring Revenue realized during the 12 months following the acquisition.    
Exchangeable shares issued   1,647,287  
Exchangeable shares outstanding   1,647,287  
Shares issued for exchangeable shares   1,020,062  
Value of shares issued for exchangeable shares $ 25,203,000 $ 7,803,475